Practice Location

10767 ILLINOIS ST STE 3000
CARMEL, IN 46032-8972

Phone: (317) 817-1200

What does JOEL BOAZ research?

Dr. Boaz studies a range of medical conditions, including erectile dysfunction, kidney cancer, rare brain tumors, and neurofibromatosis. One significant area of his research is the use of stem cell therapy to treat erectile dysfunction, revealing promising results for patients who have not benefited from traditional treatments. He also investigates uncommon cancers, such as TFE3-rearranged renal cell carcinoma, to enhance diagnosis and avoid unnecessary treatments. Additionally, Dr. Boaz explores infections related to ventricular shunts in children and looks for new procedures to treat hydrocephalus effectively.

Key findings

  • Stem cell therapy can enhance erectile function, showing promising outcomes in both animal and human studies, although many studies had limitations in size and quality.
  • In a case study, TFE3-rearranged renal cell carcinoma was misidentified as transitional cell carcinoma, underscoring the need for accurate diagnosis to prevent unnecessary treatments.
  • A new case of Masson tumor in a newborn was identified, helping to differentiate it from metastatic cancer, which is vital to avoid unnecessary anxiety and interventions.
  • Among pediatric patients with ventricular shunts, a 4% infection rate was observed, primarily caused by common skin bacteria, highlighting the importance of infection prevention.
  • The ventricular gallbladder shunt procedure showed a 70% success rate for patients with hydrocephalus, providing an alternative for those unable to use traditional shunts.

Frequently asked questions

Does Dr. Boaz study erectile dysfunction?
Yes, Dr. Boaz researches stem cell therapy as a treatment option for erectile dysfunction.
What types of cancer has Dr. Boaz researched?
He studies various cancers, including TFE3-rearranged renal cell carcinoma and rare brain tumors.
What treatments has Dr. Boaz explored for children with hydrocephalus?
He has investigated the use of ventricular gallbladder shunts as an alternative treatment for children with hydrocephalus.
How does Dr. Boaz's work relate to kidney cancer?
His research focuses on improving the diagnosis and treatment of specific types of kidney cancer, including TFE3-rearranged renal cell carcinoma.
Is Dr. Boaz's work relevant for pediatric patients?
Yes, he conducts significant research aimed at improving outcomes for pediatric patients, particularly in the context of infections and shunt treatments.

Publications in plain English

An update on the use of stem cell therapy for erectile dysfunction.

2024

Asian journal of urology

Chakra MA, Bailly H, Klampke F, Boaz J, Jida M +3 more

Plain English
This study reviewed various research articles to assess how effective stem cell therapy (SCT) is for treating erectile dysfunction (ED). The research indicated that SCT can improve erectile function, showing encouraging results in both animals and humans, although many human studies were small and varied in quality. The ability of SCT to repair and possibly replace damaged tissues could offer a better long-term solution for patients who do not respond to traditional treatments. Who this helps: This research benefits patients with erectile dysfunction, especially those who haven't found relief from standard therapies.

PubMed

TFE3-rearranged renal cell carcinoma with tumour thrombus in the ureter mimicking invasive transitional cell carcinoma.

2023

Urology case reports

Chacko AZ, Singh S, Boaz J, Gopinathan VR, Rajadoss MP

Plain English
Researchers studied a type of kidney cancer called TFE3-rearranged renal cell carcinoma, which can spread into the ureter and appear similar to another type of cancer called transitional cell carcinoma. In a young patient, doctors initially misdiagnosed the cancer as transitional cell carcinoma based on imaging, but further tests revealed it was actually TFE3-rearranged renal cell carcinoma. Highlighting this misdiagnosis is important because catching it can prevent unnecessary treatments and complications, especially in younger patients. Who this helps: This helps young patients with kidney cancer.

PubMed

Intracranial Masson tumor: case report and literature review.

2012

Journal of neuro-oncology

Shih CS, Burgett R, Bonnin J, Boaz J, Ho CY

Plain English
This study focused on a rare brain tumor known as Masson tumor, which has appeared in only 20 cases in the brain. Researchers reported a new case of a newborn whose brain tumor seemed to be metastatic cancer, but it was actually this benign tumor. Understanding this condition is crucial because it helps doctors accurately diagnose similar cases in infants, avoiding unnecessary worry about cancer. Who this helps: This information helps doctors and infants with unexplained brain masses.

PubMed

Cranio-orbital-temporal neurofibromatosis: are we treating the whole problem?

1998

The Journal of craniofacial surgery

Havlik RJ, Boaz J

Plain English
This study looked at a rare form of neurofibromatosis that affects the head and eyes, causing various problems like swelling and abnormal growth in the skull. Researchers identified possible reasons for issues in the skull's structure, specifically a part called the sphenoid wing, and found that some treatments aren’t working well because the bone grafts used during surgery tend to break down. Understanding these problems is important for improving future treatments and ensuring better outcomes for affected patients. Who this helps: Patients with cranio-orbital-temporal neurofibromatosis and their doctors.

PubMed

Origin of organisms infecting ventricular shunts.

1988

Neurosurgery

Shapiro S, Boaz J, Kleiman M, Kalsbeck J, Mealey J

Plain English
This study looked at infections in pediatric patients who had surgeries to place or revise ventricular shunts, which help drain excess fluid from the brain. Out of 505 surgeries, 20 infections occurred, giving an overall infection rate of 4%. Most infections were caused by common skin bacteria, specifically Staphylococcus epidermidis (45%) and Staphylococcus aureus (20%), indicating that these bacteria can cause complications even though they are usually harmless on the skin. Who this helps: This information is vital for doctors and healthcare workers treating children with ventricular shunts, as it can guide them in preventing infections.

PubMed

Ventricular gallbladder shunts: an alternative procedure in hydrocephalus.

1987

Journal of pediatric surgery

West KW, Turner MK, Vane DW, Boaz J, Kalsbeck J +1 more

Plain English
This research paper studied a new method for treating hydrocephalus in children using a ventricular gallbladder shunt (VGB). Out of 25 children treated, 70% of those who were monitored long-term still had their shunts functioning well. This matters because it provides a viable option for patients who cannot use traditional shunt types due to infections or other complications. Who this helps: This helps children with hydrocephalus who have had issues with standard shunt placements.

PubMed

Presence of virus-specific DNA sequences in murine type C viruses.

1979

The Journal of general virology

Byers MJ, Avery RJ, Boaz J, Kohne DE

Plain English
This study looked at certain viruses found in mice and found that they contain specific DNA sequences that are unique to those viruses. The researchers discovered that this virus-specific DNA is mostly double-stranded and is located within the virus itself. This matters because understanding how these viruses operate at a genetic level can help in developing treatments or vaccines against similar types of infections. Who this helps: This helps researchers and healthcare professionals working on virus-related diseases.

PubMed

Frequent Co-Authors

J Kalsbeck Mohamad Abou Chakra Hugo Bailly Fabian Klampke Mouatasem Jida Ahmad Abou Yassine Ian M McElree Mohamad Moussa Arman Z Chacko Shweta Singh

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.